Home
About
FAQ
History (41)
Re: Prostate Cancer-Associated SPOP Mutations Confer Resistance to BET Inhibitors through Stabilization of BRD4.
Re: SOX2 Promotes Lineage Plasticity and Antiandrogen Resistance in TP53- and RB1-Deficient Prostate Cancer.
Re: Inhibition of the Hexosamine Biosynthetic Pathway Promotes Castration-Resistant Prostate Cancer.
Clinical and Growth Correlates of Retinopathy of Prematurity in Preterm infants with Surgical Necrotizing Enterocolitis and intestinal Perforation.
Tissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapy.
See All 41 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapy.
Hipp J, Atala A. Tissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapy. J Exp Clin Assist Reprod. 2004 Dec 08; 1(1):3.
View in:
PubMed
authors with profiles
Anthony Atala MD